Private Equity Hospitals Linked to Lower Quality Respiratory Care - Summary - MDSpire

Private Equity Hospitals Linked to Lower Quality Respiratory Care

  • By

  • Debbie Bunch

  • May 19, 2026

Share

Objective:

To evaluate the quality of respiratory care in hospitals owned by private equity firms compared to non-private equity hospitals, focusing on specific metrics such as patient outcomes and service delivery.

Key Findings:
  • Hospitals acquired by private equity firms often have worse outcomes, with specific statistics indicating a significant difference in patient recovery rates.
  • There is a rapid increase in the number of U.S. hospitals owned by private equity, raising concerns among healthcare professionals.
Interpretation:

The findings suggest that private equity ownership may negatively impact the quality of respiratory care provided in hospitals.

Limitations:
  • Access to the full study is restricted to AARC members, which limits the ability of the broader medical community to evaluate the findings.
  • Further research is needed to establish causation, as correlation does not imply causation.
Conclusion:

The trend of private equity ownership in hospitals raises concerns about the quality of care, particularly in respiratory services.

Original Source(s)

Private Equity Hospitals Linked to Lower Quality Respiratory Care

  • by Debbie Bunch

  • May 19, 2026

Related Content

LC9 Scores Tied to Better Lung Health in NHANES Analysis

Cross-sectional study linked higher cardiovascular health scores with fewer respiratory symptoms and higher lung function measures among US adults

Flu Hospitalization Tied to Diabetes Risk

A large English cohort study found influenza hospitalization more than doubled the short-term risk of new-onset diabetes, with prediabetes and critical care admission among the strongest predictors.

Recent Rates of Systemic Treatment for Metastatic NSCLC in Older Adults

In a cohort study reported in JAMA Oncology, Fox et al found that approximately half of older patients with metastatic non–small cell lung cancer (NSCLC) have received systemic therapy in the United S...